At the Primary Care Center of Clear Lake, our medically guided tirzepatide program stands apart from at-home or unsupervised approaches in several crucial ways
The weight loss plateau and whether alternating actually helps Let us address the elephant in the room
Gregg EW, Buckley J, Ali MK, Davies J, Flood D, Mehta R, Griffiths B, Lim LL, Manne-Goehler J, Pearson-Stuttard J et al (2023) Improving health outcomes of people with diabetes: target setting for the WHO global diabetes compact
Whilst the use of DPP-4 inhibitors may theoretically support weight loss in the treatment of obesity through increasing the half-life of endogenous GLP-1, weight loss associated with their use is clinically insignificant (0.160.64 kg) [29], and as such their use in obesity is not explored further in this manuscript
Reference materials are provided to support laboratory review, pathway discussion, and peptide purity verification context
Ethics declarations Conflict of Interest Robert M